Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-492-4 | CAS number: 96-24-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was not run according to guideline; however, it was conducted appropriately. Limited tissues were analyzed; No analytical information was available regarding test substance used.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Lack of effect on rat testicular organogenesis after in utero exposure to 3-monochloropropane-1,2-diol (3-MCPD)
- Author:
- El Ramy R, Elhkim MO, Poul M, Forest MG, Leduque P, and Le Magueresse-Battistoni B
- Year:
- 2 006
- Bibliographic source:
- Reproductive Toxicology 22 (2006) 485-492
Materials and methods
- Objective of study:
- absorption
- distribution
- metabolism
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The levels of 3-MCPD and its main metabolite, beta-chlorolactic acid, were assayed in fetal tissues and dam plasma following a single oral dose of 25 mg/kg BW of 3-MCPD to three pregnant Sprague-Dawley rats per sampling time.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 3-chloropropane-1,2-diol
- EC Number:
- 202-492-4
- EC Name:
- 3-chloropropane-1,2-diol
- Cas Number:
- 96-24-2
- Molecular formula:
- C3H7ClO2
- IUPAC Name:
- 3-chloropropane-1,2-diol
- Reference substance name:
- 3-monochloropropane-1,2-diol
- IUPAC Name:
- 3-monochloropropane-1,2-diol
- Details on test material:
- - Name of test material (as cited in study report): 3-monochloropropane-1,2-diol (3-MCPD)
- Obtained from Sigma-Aldrich Chemical Co., St. Quentin-Fallavier, France
Constituent 1
Constituent 2
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier (le Genest, France)
- Age at study initiation: 12 weeks
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: plastic cages in air conditioned room
- Diet (e.g. ad libitum): commercial food ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 h light, 12 h dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: distilled water
- Duration and frequency of treatment / exposure:
- Single oral exposure on day 14.5 postcoitum
Doses / concentrations
- Remarks:
- Doses / Concentrations:
25 mg/kg bw
- No. of animals per sex per dose / concentration:
- 3 pregnant females per sampling time
- Control animals:
- yes, concurrent vehicle
- Positive control reference chemical:
- The method was validated using plasma supplemented with 2 - 80 ug/g or mL of 3-MCPD or beta-chlorolactic acid.
- Details on study design:
- - Dose selection rationale: Based on preliminary experiments, doses of 3-MCPD greater than 50 mg/kg induced an excess of maternal and fetal toxicity. Therefore, an exposure of 25 mg/kg BW was chosen for the current study.
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: plasma (3 dams per sampling time) and fetal tissue. Dam blood was removed and the plasma was collected by centrifugation (600 × g for 15 min at 4 deg C). The placental/fetal units were removed from the uterus and the fetuses were separated from the placenta, sampled, and weighed. Plasma and tissues were stored at −80 deg C.
- Time and frequency of sampling: 0.5, 1, 2, 3, 5, and 8 hours post-exposure
- Other: To characterize the distribution kinetics of 3-MCPD and beta-chlorolactic acid, the data were estimated by a non-compartmental analysis using WinNonlin 4.01 pharmacokinetic software (Pharsight, Mountain View, CA). This software provided parameters including the maximum concentration (Cmax), the time to reach maximum concentration (Tmax), the area under the concentration–time curve during the period of observation (AUC0−t) and the mean residence time (MRT0−t). The fetus-to-plasma partition coefficient was determined by the ratio AUCfetus,0−t/AUCplasma,0−t. The density of rat plasma was considered equal to 1 g/mL.
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled: plasma (3 dams per sampling time) and fetal tissue. Dam blood was removed and the plasma was collected by centrifugation (600 × g for 15 min at 4 deg C). The placental/fetal units were removed from the uterus and the fetuses were separated from the placenta, sampled, and weighed. Plasma and tissues were stored at −80 deg C.
- Time and frequency of sampling: 0.5, 1, 2, 3, 5, and 8 hours post-exposure
- From how many animals: 3 animals per sampling time
- Method type(s) for identification: Gas chromatography analysis of 3-MCPD and beta-chlorolactic acid was performed. Approximately 100 mg of fetal tissue or 100 uL of dam plasma was extracted using 800 or 300 uL acetonitrile, respectively. After centrifugation (5 min, 20,000 × g, at 4 deg C), the supernatant was collected and evaporated to dryness at 60 deg C under a gentle stream of nitrogen. One-hundred microlitres of HMDS/TMCS/pyridine (3/1/9) mixture was added to the sample extracts. The mixture was quickly sonicated and heated at 50 deg C for 10 min. After cooling at room temperature for 5 min, 200 uL of hexane and 200 uL of the internal standard (hexadecane, 0.1 mg/mL in hexane) were added, vortexed, and the mixture was centrifuged for 2 min at 20,000 × g at 4 deg C. A 2 uL aliquot of the supernatant was injected into the gas chromatograph for analysis of 3-MCPD and beta-chlorolactic acid. Gas chromatography analysis was carried out on a Hewlet-Packard 5890 equipped with a FID detector and an Ultra-2 (Hewlet–Packard) fused-silica capillary column (25 m, 0.2 mm i.d., 0.33 um film thickness). Ultra-high purity helium was used as the carrier gas at a constant flow rate of 0.9 mL/min. A split–splitless injection system operating in the split mode (3 mL/min) with a quartz 4 mm i.d. deactivated injector liner, packed with silica beads, was used. Operating conditions for gas chromatography were: column temperature 0 min at 80 deg C, 10 deg C/min–200 deg C, 40 deg C/min–280 deg C hold for 5 min, injector temperature 250 deg C and detector temperature 300 deg C. For each run, two replicates of fetal tissues or plasma spiked with 5 and 20 ug/g or mL of 3-MCPD and beta-chlorolactic acid were used. The average retention times for 3-MCPD and beta-chlorolactic acid derivatives were 6.6 and 7.4 min, respectively. The method was validated using untreated rat fetal tissue or plasma supplemented with 2–80 ug/g or mL of 3-MCPD or beta-chlorolactic acid.
- Limits of detection and quantification: For 3-MCPD, the limit of quantification of the method was 2 ug/g. - Statistics:
- The data are presented as the mean +/- S.D. Statistical analysis of data was performed by ANOVA, and pairwise comparisons were made using the Dunnett’s test. A p-value of 0.05 or less was determined to be statistically significant.
Results and discussion
- Preliminary studies:
- No data
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- 3-MCPD and beta-chlorolactic acid were detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration
- Type:
- distribution
- Results:
- 3-MCPD and beta-chlorolactic acid were detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration
- Type:
- metabolism
- Results:
- Beta-chlorolactic acid was detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration of 3-MCPD
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- 3-MCPD and beta-chlorolactic acid were detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration (see table below). However, 5 h after administration, the plasma and tissue levels of 3-MCPD were under the LOQ (2 ug/g).
- Details on distribution in tissues:
- 3-MCPD and beta-chlorolactic acid were detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration (see table below). However, 5 h after administration, the plasma and tissue levels of 3-MCPD were under the LOQ (2 ug/g).
Transfer into organs
- Test no.:
- #1
- Transfer type:
- blood/placenta barrier
- Observation:
- distinct transfer
- Details on excretion:
- Not measured.
Toxicokinetic parametersopen allclose all
- Test no.:
- #1
- Toxicokinetic parameters:
- Cmax: 16.4 ug/g in dam plasma at 30 min after administration. (3-MCPD)
- Test no.:
- #1
- Toxicokinetic parameters:
- Cmax: 14.3 ug/g in fetal tissue at 1 h after administration. (3-MCPD)
- Test no.:
- #1
- Toxicokinetic parameters:
- Cmax: 10.0 ug/g in dam plasma at 1 h after administration. (beta-chlorolactic acid)
- Test no.:
- #1
- Toxicokinetic parameters:
- Cmax: 9.5 ug/g in fetal tissue at 2 h after administration. (beta-chlorolactic acid)
- Test no.:
- #1
- Toxicokinetic parameters:
- other: Mean partition coefficients were 0.93 and 1.08 for 3-MCPD and beta-chlorolactic acid, respectively.
- Test no.:
- #1
- Toxicokinetic parameters:
- other: MRT0-3h of 3-MCPD was 1.26 h in plasma and 1.31 h in fetus.
- Test no.:
- #1
- Toxicokinetic parameters:
- other: MRT0-5h of beta-chlorolactic acid was 2.06 h in plasma and 2.32 h in fetus.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Beta-chlorolactic acid was detected in maternal plasma and fetal tissues at all sampling times between 30 min and 5 h after administration of 3-MCPD (see table below).
Any other information on results incl. tables
3-MCPD and Beta-chlorolactic acid concentrations in fetal tissues and dam plasma (mean +/- S.D.; LOQ = 2 ug/g or mL)
3-MCPD |
Beta-chlorolactic acid
|
||||
Sampling time (h) |
Fetus (ug/g) |
Dam plasma (ug/mL) |
Fetus (ug/g) |
Dam plasma (ug/mL) |
|
0.5 |
13.2 +/- 1.2 |
16.5 +/- 0.6 |
5.1 +/- 0.9 |
7.5 +/- 1.2 |
|
1 |
14.3 +/- 2.7 |
15.1 +/- 1.6 |
8.8 +/- 1.2 |
10.0 +/- 0.3 |
|
2 |
7.8 +/- 1.2 |
7.5 +/- 0.1 |
9.6 +/- 1.9 |
8.5 +/- 0.7 |
|
3 |
4.0 +/- 1.0 |
4.4 +/- 0.8 |
7.7 +/- 1.8 |
5.8 +/- 0.9 |
|
5 |
< LOQ |
< LOQ |
3.3 +/- 0.5 |
2.1 +/- 0.4 |
|
8 |
< LOQ |
< LOQ |
< LOQ |
< LOQ |
|
|
Applicant's summary and conclusion
- Conclusions:
- 3-MCPD and beta-chlorolactic acid (the main metabolite of 3-MCPD) were found to readily cross the placental barrier and diffuse throughout the fetal tissues.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.